Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLRS
3826
Kalaris Therapeutics
KLRS
$96.8M
| $215K | ﹤0.01% |
26,787
+1,362
| +5% | +$13.3K |
|
3827
LGL Group
LGL
$46.5M
| $215K | ﹤0.01% |
32,860
+4,143
| +14% | +$27.3K |
|
3828
Cadrenal Therapeutics
CVKD
$6.96M
| $213K | ﹤0.01% |
12,086
+1,532
| +15% | +$28.2K |
|
3829
MultiSensor AI
MSAI
$10.7M
| $213K | ﹤0.01% |
5,715
+1,223
| +27% | +$68.2K |
|
3830
Clene
CLNN
$67.5M
| $212K | ﹤0.01% |
68,970
+3,858
| +6% | +$17.5K |
|
3831
Paramount Gold Nevada
PZG
$124M
| $212K | ﹤0.01% |
573,187
+33,220
| +6% | +$12.3K |
|
3832
CPS Technologies
CPSH
$86.1M
| $211K | ﹤0.01% |
132,882
+22,096
| +20% | +$37.6K |
|
3833
Air T
AIRT
$86.1M
| $211K | ﹤0.01% |
12,498
+728
| +6% | +$13.9K |
|
|
YARW
3834
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $211K | ﹤0.01% |
2,670
-30
| -1% | -$3.69K |
|
3835
Home Federal Bancorp
HFBL
$71.5M
| $211K | ﹤0.01% |
16,124
+892
| +6% | +$11.5K |
|
|
MACI
3836
Melar Acquisition Corp I
MACI
$236M
| $209K | ﹤0.01% |
+20,430
| New | +$208K |
|
|
RBOT
3837
DELISTED
Vicarious Surgical
RBOT
| $209K | ﹤0.01% |
31,803
+1,004
| +3% | +$11.9K |
|
3838
TechPrecision Corp
TPCS
$49.7M
| $209K | ﹤0.01% |
90,649
+8,693
| +11% | +$25.5K |
|
|
KGEI
3839
Kolibri Global Energy
KGEI
$181M
| $208K | ﹤0.01% |
+24,819
| New | +$187K |
|
3840
AMCON Distributing
DIT
| $207K | ﹤0.01% |
2,652
+297
| +13% | +$25.5K |
|
|
MREO
3841
Mereo BioPharma
MREO
$47.3M
| $207K | ﹤0.01% |
92,156
| – | – |
|
|
BSIN
3842
Big Sky Industrial
BSIN
$63.3M
| $207K | ﹤0.01% |
172,711
+61,183
| +55% | +$116K |
|
3843
Tigo Energy
TYGO
$93.7M
| $204K | ﹤0.01% |
243,331
+8,438
| +4% | +$7.95K |
|
|
GOOS
3844
Canada Goose Holdings
GOOS
$856M
| $204K | ﹤0.01% |
25,748
+1,953
| +8% | +$19.3K |
|
|
GGRP
3845
Glimpse Group
GGRP
$18.7M
| $204K | ﹤0.01% |
175,677
+18,781
| +12% | +$30.8K |
|
|
LGCY
3846
Legacy Education Inc
LGCY
$145M
| $203K | ﹤0.01% |
28,248
+2,974
| +12% | +$23.4K |
|
3847
CVD Equipment Corp
CVV
$56.8M
| $202K | ﹤0.01% |
65,717
+5,833
| +10% | +$20K |
|
3848
Hess Midstream
HESM
$5.11B
| $201K | ﹤0.01% |
+4,752
| New | +$194K |
|
|
RYM
3849
RYTHM Inc
RYM
$49M
| $200K | ﹤0.01% |
+11,419
| New | +$246K |
|
|
TVRD
3850
Tvardi Therapeutics
TVRD
$23.4M
| $200K | ﹤0.01% |
13,122
+561
| +4% | +$8.47K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.